Cisiv

Software Development • London, England, United Kingdom • 21-50 Employees

Company overview

Headquarters	London, England, United Kingdom
Phone number	+442089398470
Website	cisiv.com
SIC	737
Keywords	Software, Clinical Research, Data Management, EDC, Web 2.0, Observational Studies, Non-Interventional Studies, Real-World Data, Phase Iv, Post-Approval
Employees	21-50
Socials

Key Contacts at Cisiv

Dominic Farmer

Managing Director

Sohan Krishna

Product Director

Ruth Whittaker

Finance And Admin Director

Cisiv Email Formats

Cisiv uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@cisiv.com), used 63.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@cisiv.com	63.6%
{first initial}	j@cisiv.com	18.2%
{first name}.{last name}	john.doe@cisiv.com	18.2%

About Cisiv

Cisiv’s technology platform is fit-for-purpose and enables Pharmaceutical and Medical Device companies to collect and manage safety and efficacy studies in the real world. Through our technology, organizations are able to expand their global reach and provide access to more patients. The platform, Baseline plus, spans every aspect of data collection and analysis as well as complex workflows for stakeholder engagement. This intuitive, modular web-based platform is highly configurable, providing unrivalled flexibility, no matter the scope or scale and has proven to reduce data management costs by 60%. Baseline Plus is an industry leading platform, including EDC, eConsent, ePRO, eCOA, eDiary, Surveys, Safety, e-Source, with functionality suitable for site-based, decentralized, and hybrid research. Currently, Cisiv’s intelligent platform is utilized by 90% of the top global pharmaceutical companies and has supported 200+ projects with pharma and biotech organizations.

Cisiv revenue & valuation

Annual revenue	$7,000,000
Revenue per employee	$280,000
Estimated valuation?This valuation is estimated based on industry average for the Software Development industry and current estimated revenues	$22,400,000
Total funding	No funding